Richard A. Young - 10 Jan 2023 Form 4 Insider Report for Omega Therapeutics, Inc. (OMGAQ)

Role
Director
Signature
/s/ Barbara Chan as Attorney-in-Fact for Richard A. Young, Ph.D.
Issuer symbol
OMGAQ
Transactions as of
10 Jan 2023
Net transactions value
-$160,000
Form type
4
Filing time
11 Jan 2023, 15:14:41 UTC
Previous filing
19 Sep 2022
Next filing
20 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OMGA Common Stock Sale $160,000 -20,000 -2.6% $8.00 764,118 10 Jan 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 31, 2022.